Table 3. Multivariate analysis using the seven prognostic variables in the univariate analyses.
|
Multivariate analysis
|
||
|---|---|---|
| Variables | Risk ratio (95% CI) | P-value |
| Peritoneal tumour spread at PCS | ||
| Localised to the pelvis | 1.00 | |
| Extended beyond the pelvis | 0.80 (0.42–1.76) | 0.540 |
| Stage | ||
| I/II | 1.00 | |
| III/IV | 0.90 (0.22–5.60) | 0.893 |
| Aortic lymph node metastases at PCS | ||
| Absent | 1.00 | |
| Present | 1.23 (0.56–2.64) | |
| Not assessed | 1.78 (0.61–5.33) | 0.088 |
| Disease-free interval (months) | ||
| ⩾12 | 1.00 | |
| <12 | 2.45 (1.11–5.39) | 0.027 |
| Liver metastasis | ||
| Absent | 1.00 | |
| Present | 4.00 (1.40–10.03) | 0.013 |
| No. of recurrent tumours | ||
| Solitary | 1.00 | |
| Multiple | 3.73 (1.79–9.58) | <0.001 |
| Size of maximum tumour (cm) | ||
| <6 | 1.00 | |
| ⩾6 | 7.43 (3.12–18.92) | <0.001 |
PCS=primary cytoreductive surgery.